Eli Lilly touts long-term safety data for Olumiant amid classwide scrutiny on JAK meds aliu Wed, 11/10/2021 – 11:30 More: Eli Lilly touts long-term safety data for Olumiant amid classwide scrutiny on JAK meds Source: fierce
read moreMerck inks yet another $1B-plus supply deal for COVID pill, this time with Japan esagonowsky Wed, 11/10/2021 – 11:01 More: Merck inks yet another B-plus supply deal for COVID pill, this time with Japan Source: fierce
read moreModerna, U.S. clash in patent dispute over origins of COVID-19 vaccine: report kdunleavy Wed, 11/10/2021 – 10:56 More: Moderna, U.S. clash in patent dispute over origins of COVID-19 vaccine: report Source: fierce
read moreAstraZeneca, FibroGen hope to keep their roxadustat dream alive with new FDA meeting aliu Wed, 11/10/2021 – 09:40 More: AstraZeneca, FibroGen hope to keep their roxadustat dream alive with new FDA meeting Source: fierce
read moreValneva to supply up to 60 million doses of its inactivated COVID-19 vaccine candidate over a period of two years More: EC approves Valneva COVID-19 vaccine deal Source: News
read moreThe new research by Heriot-Watt University has identified a way of targeting an enzyme called EPAC1 More: 'Ground-breaking' research on inflammatory disease treatment set to be commercialised Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals